A+ HEALTH
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 18 Apr 2025)
What this means for you
Registered since 03 Dec 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88976024
- Registration number
- 5928920
- Mark type
- Stylized text
- Filed
- 14 Aug 2018
- Published for opposition
- 29 Jan 2019
- Registered
- 03 Dec 2019
- Attorney of record
- Jane S. Berman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for medical use in humans, namely, pharmaceutical preparations containing ibuprofen for treatment of pain, pharmaceutical preparations containing cetirizine for treatment of colds or allergies
Owner
- Bionpharma Inc., Princeton, NJ, US
- Bionpharma Inc., Princeton, NJ, US
- Bionpharma Inc., Princeton, NJ, US
Prosecution history
- 18 Apr 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 18 Apr 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 18 Apr 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 07 Jan 2025 — TEAS SECTION 8 & 15 RECEIVED
- 03 Dec 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 21 Oct 2020 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 03 Dec 2019 — REGISTERED-PRINCIPAL REGISTER
- 30 Oct 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 29 Oct 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Oct 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Sept 2019 — USE AMENDMENT FILED
- 16 Oct 2019 — DIVISIONAL PROCESSING COMPLETE
- 18 Sept 2019 — DIVISIONAL REQUEST RECEIVED
- 01 Oct 2019 — RESPONSE TO ITU OFFICE ACTION ENTERED
- 01 Oct 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED